Judge To Consider Class In Pfizer's Neurontin Cases

Law360, New York (January 23, 2007, 12:00 AM EST) -- Nearly three years after criminal charges were settled in Pfizer Inc.’s illegal marketing of the epilepsy drug Neurontin, a federal judge is considering whether or not to grant class action status in nearly 200 consolidated civil lawsuits.

Plaintiffs’ lawyers on Monday said both parties agreed that a hearing on class certification should be held during the second half of April, while also filing a motion for more time to respond to Pfizer’s expert reports.

The product liability cases were consolidated in 2005 by Magistrate Judge Leo...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.